- Home
- CLEU vs XAIR Comparison
CLEU vs XAIR Comparison
Compare CLEU & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLEU
- XAIR
- Stock Information
- Founded
- CLEU 2011
- XAIR 2011
- Country
- CLEU China
- XAIR United States
- Employees
- CLEU N/A
- XAIR N/A
- Industry
- CLEU Other Consumer Services
- XAIR Medical/Dental Instruments
- Sector
- CLEU Real Estate
- XAIR Health Care
- Exchange
- CLEU Nasdaq
- XAIR Nasdaq
- Market Cap
- CLEU 29.3M
- XAIR 27.7M
- IPO Year
- CLEU 2020
- XAIR N/A
- Fundamental
- Price
- CLEU $0.09
- XAIR $0.35
- Analyst Decision
- CLEU
- XAIR Strong Buy
- Analyst Count
- CLEU 0
- XAIR 4
- Target Price
- CLEU N/A
- XAIR $3.67
- AVG Volume (30 Days)
- CLEU 51.5M
- XAIR 1.5M
- Earning Date
- CLEU 10-11-2024
- XAIR 02-10-2025
- Dividend Yield
- CLEU N/A
- XAIR N/A
- EPS Growth
- CLEU N/A
- XAIR N/A
- EPS
- CLEU N/A
- XAIR N/A
- Revenue
- CLEU $2,413,409.00
- XAIR $3,023,000.00
- Revenue This Year
- CLEU N/A
- XAIR $244.61
- Revenue Next Year
- CLEU N/A
- XAIR $258.76
- P/E Ratio
- CLEU N/A
- XAIR N/A
- Revenue Growth
- CLEU N/A
- XAIR 338.75
- 52 Week Low
- CLEU $0.09
- XAIR $0.30
- 52 Week High
- CLEU $7.90
- XAIR $2.11
- Technical
- Relative Strength Index (RSI)
- CLEU 31.94
- XAIR 41.74
- Support Level
- CLEU $0.09
- XAIR $0.34
- Resistance Level
- CLEU $0.11
- XAIR $0.40
- Average True Range (ATR)
- CLEU 0.02
- XAIR 0.05
- MACD
- CLEU -0.10
- XAIR -0.00
- Stochastic Oscillator
- CLEU 1.10
- XAIR 10.21
About CLEU China Liberal Education Holdings Limited
China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.